Credit Suisse lowered the firm’s price target on Labcorp to $288 from $304 and keeps an Outperform rating on the shares. The firm is also updating the breakdown of its 2023 metrics to reflect lowered revenues, op income, and EPS in the first half of the year and raised metrics in the back half.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on LH: